IDEAS home Printed from https://ideas.repec.org/a/taf/indinn/v29y2022i1p25-52.html
   My bibliography  Save this article

The impact of product innovation announcements on firm value: evidence from the bio-pharmaceutical industry

Author

Listed:
  • Jan Niederreiter
  • Massimo Riccaboni

Abstract

We investigate the impact of product innovation announcements on firm value using an extensive data set of bio-pharmaceutical products. We find that two main effects shape observed firm value changes: a ‘probability effect’, which depends on how investors perceive the product’s likelihood of success, and a ‘portfolio effect’ that depends on the relative importance of a product within a company’s portfolio. We estimate product-specific success probabilities using various machine learning methods. The portfolio importance is measured by product and date-specific net present values. We find that market reactions increase in the portfolio importance of the product under development and diminish in its success probability. Our results aid corporations and investors in evaluating the financial consequences of innovation-related news.

Suggested Citation

  • Jan Niederreiter & Massimo Riccaboni, 2022. "The impact of product innovation announcements on firm value: evidence from the bio-pharmaceutical industry," Industry and Innovation, Taylor & Francis Journals, vol. 29(1), pages 25-52, January.
    • Handle: RePEc:taf:indinn:v:29:y:2022:i:1:p:25-52
    DOI: 10.1080/13662716.2021.1967729
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1080/13662716.2021.1967729
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1080/13662716.2021.1967729?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Semen Budennyy & Alexey Kazakov & Elizaveta Kovtun & Leonid Zhukov, 2022. "New drugs and stock market: how to predict pharma market reaction to clinical trial announcements," Papers 2208.07248, arXiv.org, revised Aug 2022.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:indinn:v:29:y:2022:i:1:p:25-52. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/CIAI20 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.